Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Ho

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Journal of Geriatric Oncology|November 7, 2020
Patient-reported psychosocial needs and psychological distress predict survival in geriatric oncology patientsBonnie Leung, Aria Shokoohi, Alan Bates, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomesCheryl Ho, Jennifer Siegfried, Karen Remo, et al.
Clinical Colorectal Cancer|December 17, 2005
Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysisCheryl Ho, Kathy Ng, Susan O'Reilly, et al.
Radiation Oncology (London, England)|February 1, 2020
Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patientsSara Moore, Bonnie Leung, Jonn Wu, et al.
Clinical Lung Cancer|August 8, 2007
Dual inhibition: combining epidermal growth factor-targeted therapies in non-small-cell lung cancerCheryl Ho, Angela Davies, Philip Mack, et al.
JTO Clinical and Research Reports|September 30, 2021
Survival Outcomes of Salvage Therapy for Local and Regionally Recurrent NSCLCSara Moore, Bonnie Leung, Jonn Wu, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care UtilizationRebekah Rittberg, Bonnie Leung, Zamzam Al-Hashami, et al.
Journal of Oncology Practice|September 15, 2018
CNS Metastases in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: Impact on Health Resource UtilizationNegar Chooback, Shilo Lefresne, Sally C Lau, et al.
Thyroid Research|September 22, 2017
A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapyGeorgia Geller, Janessa Laskin, Winson Y Cheung, et al.
Clinical Lung Cancer|June 11, 2019
Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based CohortSally C Lau, Negar Chooback, Cheryl Ho, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Journal of Geriatric Oncology|November 7, 2020
Patient-reported psychosocial needs and psychological distress predict survival in geriatric oncology patientsBonnie Leung, Aria Shokoohi, Alan Bates, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomesCheryl Ho, Jennifer Siegfried, Karen Remo, et al.
Clinical Colorectal Cancer|December 17, 2005
Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysisCheryl Ho, Kathy Ng, Susan O'Reilly, et al.
Radiation Oncology (London, England)|February 1, 2020
Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patientsSara Moore, Bonnie Leung, Jonn Wu, et al.
Clinical Lung Cancer|August 8, 2007
Dual inhibition: combining epidermal growth factor-targeted therapies in non-small-cell lung cancerCheryl Ho, Angela Davies, Philip Mack, et al.
JTO Clinical and Research Reports|September 30, 2021
Survival Outcomes of Salvage Therapy for Local and Regionally Recurrent NSCLCSara Moore, Bonnie Leung, Jonn Wu, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Real World Patient Eligibility for Second Line Lurbinectedin Based Treatment in Small Cell Lung Cancer: Understanding Epidemiology and Estimating Health Care UtilizationRebekah Rittberg, Bonnie Leung, Zamzam Al-Hashami, et al.
Journal of Oncology Practice|September 15, 2018
CNS Metastases in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: Impact on Health Resource UtilizationNegar Chooback, Shilo Lefresne, Sally C Lau, et al.
Thyroid Research|September 22, 2017
A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapyGeorgia Geller, Janessa Laskin, Winson Y Cheung, et al.
Clinical Lung Cancer|June 11, 2019
Outcome Differences Between First- and Second-generation EGFR Inhibitors in Advanced EGFR Mutated NSCLC in a Large Population-based CohortSally C Lau, Negar Chooback, Cheryl Ho, et al.
Pageof 12